Seroprevalence of coxsackievirus A16 antibody among people of various age groups: a systematic review and meta-analysis
Open Access
- 17 September 2021
- journal article
- review article
- Published by Springer Nature in Archives of Public Health
- Vol. 79 (1) , 1-8
Abstract
Background: Coxsackie virus group A type 16 (CoxA16) is the main pathogen and usually an alternative to or joins in prevalence with enterovirus 71 (EV71) causing hand, foot and mouth disease (HFMD). The objective of this study was to estimate the seroprevalence of CoxA16 antibody among people of various age groups by a systematic review and meta-analysis. Methods: The literature of seroprevalence of CoxA16 antibody among people has been systematically searched through databases from the date of their establishment to Jan. 2021. Estimates of seroprevalence of CoxA16 antibody by gender and age groups have been summarized by using fixed- and random- effect models. All analyses have been conducted in STATA version 12.0 software. Results: A total of 14 publications with 9 in English and 5 in Chinese containing 9562 samples were finally included in the meta-analysis. The seroprevalence of CoxA16 antibody reported in different studies range from 24.85 to 76.92 %. Meta-analysis has revealed that the seroprevalence of CoxA16 antibody was 56.3 % (95 %CI: 47.7 %~64.9 %) in the overall population and 55.1 % (95 %CI: 44.1 %~66.1 %) in the Chinese population. Subgroup analysis by gender has revealed that the seroprevalence of CoxA16 antibody was 56.1 % (95 %CI: 45.2 %~67.1 %) in males and 60.0 % (95 %CI: 50.0 %~69.9 %) in females. Subgroup analysis by age groups has revealed that the seroprevalence of CoxA16 antibody was 49.1 % (95 %CI: 36.2 %~62.0 %) in the 0 ~ 5 age group and 63.9 % (95 %CI: 53.1 %~74.7 %) in the over 5 age group. Begg’s funnel plots have suggested that there were no publication bias in all groups. Sensitive analysis has suggested that the result of the meta-analysis was stable. Conclusions: The seroprevalence of CoxA16 antibody was closely related to age. Children under 5 years old were the main susceptible groups for CoxA16 and also the key groups for the prevention and control of HFMD.Keywords
Funding Information
- Bureau of Science and Technology of Zhoushan (2017C31125, 2018C31118, 2017B02)
This publication has 23 references indexed in Scilit:
- Risk factors of severe hand, foot and mouth disease: A meta-analysisScandinavian Journal of Infectious Diseases, 2014
- Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in ChinaEmerging Microbes & Infections, 2014
- Seroprevalence of Human Enterovirus 71 and Coxsackievirus A16 in Guangdong, China, in Pre- and Post-2010 HFMD Epidemic PeriodPLOS ONE, 2013
- Coxsackievirus A16Human Vaccines & Immunotherapeutics, 2013
- Detection of human enterovirus 71 and Coxsackievirus A16 in an outbreak of hand, foot, and mouth disease in Henan Province, China in 2009Virus Genes, 2012
- Retrospective Study of the Incidence of HFMD and Seroepidemiology of Antibodies against EV71 and CoxA16 in Prenatal Women and Their InfantsPLOS ONE, 2012
- Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008Virology Journal, 2010
- Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in GermanyMedical Microbiology and Immunology, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003
- Fixed- and random-effects models in meta-analysis.Psychological Methods, 1998